STOCK TITAN

Viatris (VTRS) director gains shares via RSU vesting and trust buys

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Viatris Inc director David S. Simmons reported compensation-related equity activity and small prior share purchases. On March 6, 2026, 22,820 restricted stock units and 523.0399 dividend equivalent units vested and were settled into 23,344 shares of common stock, with fractional shares rounded up under the RSU award terms. On the same date, he received a new grant of 15,890 restricted stock units that will vest on March 6, 2027, each RSU representing one common share.

The filing also shows earlier open-market purchases by family trusts associated with Simmons in 2025, totaling 499 shares of common stock at prices around $10.42 per share. According to the footnotes, these trust purchases were executed by investment advisors in managed accounts designed to mirror certain index funds.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SIMMONS DAVID S

(Last) (First) (Middle)
1000 MYLAN BOULEVARD

(Street)
CANONSBURG PA 15317

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Viatris Inc [ VTRS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/27/2025 P(1) 286 A $10.423(2) 970 I By Family Trusts
Common Stock 11/03/2025 P(1) 213 A $10.4255(2) 1,183 I By Family Trusts(3)
Common Stock 03/06/2026 M 22,820 A $0 22,820 D
Common Stock 03/06/2026 M 524(4) A $0 23,344 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0 03/06/2026 M 22,820 (5) (5) Common Stock 22,820 $0 0 D
Dividend Equivalent Units $0 03/06/2026 M 523.0399 (6) (6) Common Stock 523.0399 $0 0 D
Restricted Stock Units $0 03/06/2026 A 15,890 (7) (7) Common Stock 15,890 $0 15,890 D
Explanation of Responses:
1. These shares were acquired by the reporting person's investment advisors in managed accounts as part of the investment advisors' implementation and continued execution of managed investment strategies to mirror certain index funds involving the securities of multiple issuers.
2. Based on information provided by the investment advisor; additional information, including the price range, if any, is unavailable.
3. These shares are held in family trusts for which the reporting person or his spouse serve as trustee: (i) 13 shares in a trust for the benefit of the reporting person for which the reporting person serves as trustee; (ii) 63 shares in a trust for the benefit of the reporting person and his children for which the reporting person serves as trustee; (iii) 522 shares in a trust for the benefit of the reporting person's spouse for which the reporting person's spouse serves as trustee; and (iv) 585 shares in trusts for the benefit of the reporting person's children for which the reporting person's spouse serves as trustee.
4. Fractional shares have been rounded up in connection with the settlement described in footnote 6 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
5. Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026.
6. Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on August 11, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.
7. Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027.
/s/ Kevin Macikowski, by power of attorney 03/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Viatris (VTRS) director David S. Simmons report on March 6, 2026?

He reported RSU vesting and a new RSU grant. 22,820 restricted stock units and 523.0399 dividend equivalent units vested into 23,344 common shares, and he received a new grant of 15,890 restricted stock units scheduled to vest on March 6, 2027.

How many Viatris (VTRS) shares did David S. Simmons receive from RSU and DEU settlement?

The vesting delivered 23,344 shares of common stock. These shares came from 22,820 restricted stock units and 523.0399 dividend equivalent units, with fractional shares rounded up according to the Viatris Inc. 2020 Stock Incentive Plan award agreement.

When will the newly granted RSUs to Viatris (VTRS) director David S. Simmons vest?

The newly granted RSUs are set to vest on March 6, 2027. Each of the 15,890 restricted stock units reported represents the right to receive one share of Viatris common stock upon vesting, subject to the award’s terms.

What prior open-market purchases involving Viatris (VTRS) stock were disclosed for David S. Simmons?

Family trusts associated with Simmons bought 499 shares in 2025. The transactions were 286 shares on August 27, 2025 and 213 shares on November 3, 2025 at prices around $10.42 per share, executed by investment advisors in managed accounts.

How are the Viatris (VTRS) shares held by David S. Simmons’ family trusts structured?

The shares are held across several family trusts where he or his spouse serve as trustee. The trusts benefit Simmons, his spouse, and their children, with specific share amounts allocated to each trust as detailed in the filing footnotes.

Were the Viatris (VTRS) trust purchases directed personally by David S. Simmons?

The filing states the purchases were made by investment advisors in managed accounts. These accounts implement strategies to mirror certain index funds, and information such as price ranges beyond the reported averages is noted as unavailable from the advisor.
Viatris Inc Ord Shs

NASDAQ:VTRS

View VTRS Stock Overview

VTRS Rankings

VTRS Latest News

VTRS Latest SEC Filings

VTRS Stock Data

16.21B
1.15B
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG